- Home
- BMNR vs PBYI Comparison
BMNR vs PBYI Comparison
Compare BMNR & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMNR
- PBYI
- Stock Information
- Founded
- BMNR 2019
- PBYI 2010
- Country
- BMNR United States
- PBYI United States
- Employees
- BMNR N/A
- PBYI N/A
- Industry
- BMNR
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- BMNR
- PBYI Health Care
- Exchange
- BMNR NYSE
- PBYI Nasdaq
- Market Cap
- BMNR 205.5M
- PBYI 171.7M
- IPO Year
- BMNR N/A
- PBYI N/A
- Fundamental
- Price
- BMNR $39.72
- PBYI $3.28
- Analyst Decision
- BMNR
- PBYI Strong Buy
- Analyst Count
- BMNR 0
- PBYI 1
- Target Price
- BMNR N/A
- PBYI $7.00
- AVG Volume (30 Days)
- BMNR 30.2M
- PBYI 351.2K
- Earning Date
- BMNR 07-11-2025
- PBYI 08-07-2025
- Dividend Yield
- BMNR N/A
- PBYI N/A
- EPS Growth
- BMNR N/A
- PBYI 143.51
- EPS
- BMNR N/A
- PBYI 0.77
- Revenue
- BMNR $5,452,545.00
- PBYI $232,709,000.00
- Revenue This Year
- BMNR N/A
- PBYI N/A
- Revenue Next Year
- BMNR N/A
- PBYI N/A
- P/E Ratio
- BMNR N/A
- PBYI $4.25
- Revenue Growth
- BMNR 89.77
- PBYI 2.68
- 52 Week Low
- BMNR $3.92
- PBYI $2.23
- 52 Week High
- BMNR $161.00
- PBYI $4.13
- Technical
- Relative Strength Index (RSI)
- BMNR N/A
- PBYI 40.98
- Support Level
- BMNR N/A
- PBYI $3.34
- Resistance Level
- BMNR N/A
- PBYI $3.55
- Average True Range (ATR)
- BMNR 0.00
- PBYI 0.13
- MACD
- BMNR 0.00
- PBYI -0.02
- Stochastic Oscillator
- BMNR 0.00
- PBYI 11.11
About BMNR BITMINE IMMERSION TECNOLOGIES INC
BitMine Immersion Technologies Inc is a blockchain technology company that is building out industrial-scale digital asset mining, equipment sales, and hosting operations. The company's primary business is data center focused, both mining Bitcoin for its account as well as hosting third-party Bitcoin mining servers. The Company's primary business is self-mining bitcoin for its own account, as well as hosting third-party equipment used in mining of digital asset coins and tokens, specifically bitcoin. Company's state of the art facilities will be specifically designed and constructed for housing mining equipment. The data centers will provide power, racks, proprietary thermodynamic management.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.